Immunoreactivity for alpha-smooth muscle actin characterizes a potentially aggressive subgroup of little basal cell carcinomas

European Journal of Histochemistry

Volumn 53, Issue 2, 2009, Pages 113-116

  Pilloni, Luca ^a   Bianco, P ^a   Manieli, C ^a   Senes, G ^a   Coni, P ^a   Atzori, L ^a   Aste, N ^a   Faa, G ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; KI 67 ANTIGEN; PROTEIN P53; TUMOR MARKER; ACTIN; ALPHA SMA PROTEIN, HUMAN; ALPHA-SMA PROTEIN, HUMAN; PROTEIN BCL 2;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER DIAGNOSIS; CANCER INVASION; CANCER RECURRENCE; CANCER SIZE; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PROTEIN EXPRESSION; ULTRAVIOLET RADIATION; LETTER; METABOLISM; MIDDLE AGED; PATHOLOGY;

ACTINS; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70349246654     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: 10.4081/ejh.2009.113     Document Type: Article

References (15)

1. Auepemikiate S, Boonyaphiphat P, Thongsuksai P. p53 expression to relate to the aggressive infiltrative histopathologic features of basal cell carcinoma. Histopathol 2002;40:568-573
2. Barsky SH, Grossmann DA, Bhuta S. Desmoplastic basal cell carcinoma possess unique basement membrane-degrading properties. J Invest Dermatol 1987;88:324-329 (Pubitemid 17035349)
3. Bayer-Garner I, Dilday B, Sanderson ND, Smoller BR. Syndecan-1 expression is decreased with increasing aggressiveness of basal cell carcinoma. Am J Dermatopathol 2000;22:119-122 (Pubitemid 30185832)
4. Bozdogan O, Erkek E, Atasoy P, Koçak M, Birol A, Caydere M. Bcl-2-related proteins, alpha-smooth muscle actin and amyloid deposits in aggressive and non-aggressive basal cell carcinomas. Acta Derm Venereol 2002;82:423-427 (Pubitemid 36140242)
5. Cribier B, Noacco G Peltre B, Grosshans E. Expression of stromelysin 3 in basal cell carcinomas. European J Dermatol 2001;11:530-533 (Pubitemid 33044450)
6. Cristian M, Moy RL, Wagner RF, Yen-Moore A. A correlation of alpha-smooth muscle actin an invasion in micronodular basal cell carcinoma. Dermatol Surg 2001;27:441-445 (Pubitemid 32436333)
7. Crowson AN. Basal cell carcinoma: biology, morphology and clinical implications. Modern Pathology 2006; 19:S127-47.
8. Hobart W. Walling, Fosko SW, Geraminejad PA, Whitaker DC, Arpey CJ. Aggressive basal cell carcinoma: Presentation, pathogenesis and management. Cancer and Metastasis Reviews 2004; 23:389-402. (Pubitemid 38881820)
9. Jones JCR, Steinman HK, Goldsmith BA. Hemidesmosomes, collagen VII and intermediate filaments in basal cell carcinoma. J Invest. Dermatol 1989; 93:662-671
10. Law AM, Oliveri CV, Pacheco-Quinto X, Horenstein MG. Actin expression in purely nodular versus nodular-infiltrative basal cell carcinoma. J Cutan Pathol. 2003; 30: 232-236 (Pubitemid 36555129)
11. Ramdial P, Madaree A, Reddy R, Chetty R. bcl-2 protein expression in aggressive and in non aggressive carcinomas. J Cutaneous Pathol 2000; 27: 283-291 (Pubitemid 30389568)
12. Snow SN, Sahl WJ, Lo JS, Mohs FE, Warner T, Dekkinga JA, Feyzi J. Metastatic basal cell carcinoma: report 5 cases. Cancer 1994;73:328-335 (Pubitemid 24030610)
13. Staibano S, Lo Muzio L, Pannone G, Scalvenzi M, Salvatore G, Errico ME, Fanali S, De Rosa G, Piatelli A. Interaction between bcl-2 and p53 in neoplastic progression of basal cell carcinoma of the head and neck. Anticancer Research 2001; 21:3757-3764
14. Urabe A, Nakayama J, Tani Guchi S, Kuroki R, Hori Y. Expression of the fos oncogene in basal cell carcinoma. J Dermatol Sci 1994;8:50-53 (Pubitemid 24237067)
15. Van der Schroeff J, Evers LM, Boot AJM, Bos JL. Ras oncogene point mutation in basal cell carcinomas and squamous cell carcinomas of the human skin. J Invest Dermatol 1990; 94:423-425 (Pubitemid 20123914)